Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice.
Res Pract Thromb Haemost
; 8(3): 102367, 2024 Mar.
Article
en En
| MEDLINE
| ID: mdl-38660455
ABSTRACT
Background:
Desmopressin is frequently used perioperatively in persons with nonsevere hemophilia A. However, increase in factor (F)VIIIC after desmopressin use is interindividually highly variable. Tachyphylaxis has only been reported in test setting for persons with hemophilia A, with a remaining response of approximately 70% after a second dose compared with that after a first dose.Objectives:
To study tachyphylaxis of FVIIIC response after multiple administration(s) of desmopressin in perioperative persons with nonsevere hemophilia A.Methods:
We studied FVIIIC levels after desmopressin before (day 0 [D0]) and on days 1 (D1) and 2 (D2) after surgery in 26 patients of the DAVID and Little DAVID studies. We studied tachyphylaxis by comparing the responses at D1 and D2 with that at D0. We also assessed the reproducibility of the D0 response in comparison to an earlier performed desmopressin test.Results:
The median absolute FVIIIC increase was 0.50 IU/mL (0.35-0.74; n = 23) at D0, 0.21 IU/mL (0.14-0.28; n = 17) at D1, and 0.23 IU/mL (0.16-0.30; n = 11) at D2. The median percentage of FVIII increase after the second administration (D1) compared with the first (D0) was 42.9% (29.2%-52.5%; n = 17) and that of the third (D2) compared with the first (D0) was 36.4% (23.7%-46.9%; n = 11). The FVIIIC desmopressin response at D0 was comparable with the desmopressin test response in 74% of the patients.Conclusion:
Tachyphylaxis in the surgical setting was considerably more pronounced than previously reported, with FVIIIC at D1 and D2 of 36% to 43% of the initial response. Our results may have important implications for monitoring repeated desmopressin treatment when used perioperatively.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Res Pract Thromb Haemost
Año:
2024
Tipo del documento:
Article
País de afiliación:
Países Bajos